Diffuse large B-cell lymphoma: Early patient management | OTT
Determining Prognosis for Patients With Diffuse Large B-Cell Lymphoma - Hematology Advisor
Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Treatment and Prognosis – Nova Science Publishers
Overall survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Progression-free survival in diffuse large B cell lymphoma patients in... | Download Scientific Diagram
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
Survival analysis in patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
Prognosis for p65 hyperactivation in diffuse large B-cell lymphoma... | Download Scientific Diagram
New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text
Cancers | Free Full-Text | Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China - Wei Wang, Jingjing Yin, Wei Zhang, Yan Zhang,
About RITUXAN® (rituximab) | Diffuse Large B Cell Lymphoma
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
RELB AS A NOVEL PROGNOSTIC BIOMARKER FOR DIFFUSE LARGE B-CELL LYMPHOMA ( DLBCL) | ERGANEO
Diffuse Large B-Cell Lymphoma | NEJM
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study | Haematologica
Prognostic Value of 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen | Journal of Nuclear Medicine
![PDF] Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/910db6912e5f808721d987fcdb285a61b2b6afb3/2-Table1-1.png "PDF] Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. | Semantic Scholar")
PDF] Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. | Semantic Scholar
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma | BMC Cancer | Full Text
Patient Information: Diffuse Large B Cell Lymphoma
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study - eBioMedicine
